Price (delayed)
$0.3936
Market cap
$15.43M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.25
Enterprise value
-$10.51M
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory,
There are no recent dividends present for AMTI.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.